In cisplatin-resistant small cell lung cancer (SCLC), napabucasin induces apoptosis by cleavage PARP and suppression of antiapoptotic proteins Mcl-1 and survivin [13]. The gene discussed is MCL1; the disease is small cell lung carcinoma.